MNC Kapital Indonesia Tbk vs Cipta Sarana Medika Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B, 12.18M 24h volume). The key difference: MNC Kapital Indonesia Tbk is far larger — about 13.3× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (12.18M versus 136K). Which is the better fit depends on your goals.
| BCAP | DKHH | |
|---|---|---|
Market Cap | 2.13T | 160.67B |
Volume | 136K | 12.18M |
Lot | 1.36K | 121.83K |
Turnover | 6.8M | 762.52M |
Average Price | 50 | 62.59 |
Value | 6.8M | 762.52M |
Indicative Equilibrium Price | 50 | 63 |
Indicative Equilibrium Volume | 1 | 2.19K |
Trailing returns across standard periods
Latest headlines on both assets
PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.
Read more on BCAP →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →